The DOI matches its Crossref record.
Smoking and endocrine ophthalmopathy: impact of smoking severity and current vs lifetime cigarette consumption
Abstract
OBJECTIVE Smoking has been associated with an increased incidence of endocrine ophthalmopathy (EO). In this study we examined the relation between smoking severity and the incidence of EO symptoms in patients with Graves’ hyperthyroidism. DESIGN Patients were prospectively followed for at least one year after the onset of hyperthyroidism. Smoking and EO status were evaluated at 3−6‐ months intervals. PATIENTS Two hundred and fifty‐three ambulatory patients with recent onset of Graves’ hyperthyroidism were studied. MEASUREMENTS The incidence of total EO symptoms, proptosis, and diplopia at any time point before and after the occurrence of Graves’ hyperthyroidism was assessed by interview and physical examination. RESULTS Smoking was associated with a 1.3‐fold increase in the overall incidence of symptomatic EO, and a 2.6 and 3.1‐fold increase in the incidence of proptosis and diplopia, respectively. The relative risk increased in parallel with the current number of cigarettes smoked per day. In contrast, lifetime tobacco use was not an independent risk factor for the development of EO symptoms. Former smokers had a significantly lower risk for the occurrence of proptosis and diplopia than active smokers with a comparable lifetime cigarette consumption. CONCLUSIONS Our data suggest that current, but not lifetime, tobacco consumption constitutes a risk for the incidence of proptosis and diplopia in patients with Graves’ hyperthyroidism, and that this risk increases with smoking severity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The risk is proportional to the number of cigarettes smoked per day, and former smokers have significantly lower risk than current smokers, even after adjusting for lifetime cigarette consumption (537).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [537]
Citations
Cited by
Sorted by citations
Items 201–228 of 228
Thyroid-related Orbitopathy: New Immunologic Concepts and Future Implications
(2007) · Springer eBooks · doi:10.1007/978-3-540-33677-8_8
Napier, C., & Pearce, S. H. S. (2016) · Endocrinology · doi:10.1007/978-3-319-29195-6_15-1
Lee, B. J., & Nelson, C. C. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0971-7_51
Eckstein, A. K., Oeverhaus, M., Stöhr, M., Dekowski, D., Berchner‐Pfannschmidt, U., Esser, J., & Möller, L. C. (2020) · Radiopraxis · doi:10.1055/a-1130-1573
Approach to the Management of Thyroid Eye Disease
Yu, S., & Yin, V. T. (2023) · Canadian Diabetes & Endocrinology Today · doi:10.58931/cdet.2023.1316
Güneş, İ. B., Yilmaz, H., & Önal, E. D. (2024) · International Ophthalmology · doi:10.1007/s10792-024-02962-9
Tobacco smoking, e-cigarette and thyroid: what are the risks of thyroid disorders
Михайловна, Б. И., Shugurova, E. S., Korchagina, M. O., Borkhoeva, T. N., & Шеремета, М. С. (2024) · Clinical and experimental thyroidology · doi:10.14341/ket12776 · Cited by 1
Graves-Basedow ophthalmopathy surgical approaches: Open vs Endoscopic
Facchini, V., Piccirilli, A., Colangeli, W., et al. (2024) · Journal of Cranio-Maxillofacial Surgery · doi:10.1016/j.jcms.2024.06.004
Perros, P. (2024) · Copernicus books · doi:10.1007/978-3-031-58287-5_6
CURRENT ASPECTS OF THYROID DISEASE
(2001) · The Journal of the Royal College of Physicians of Edinburgh · doi:10.1177/1478271520013103002
“14 It is agreed by many (though not all) that radioiodine therapy may exacerbate the condition, and that this is ameliorated by a six to eight week course of prednisolone at the time of therapy.”
(2000) · Time to knit · doi:10.1016/s0246-0343(13)54363-2
(2000) · Time to knit · doi:10.1016/s0246-0343(20)41647-8
Eckstein, A. K., Oeverhaus, M., Möller, L. C., & Führer‐Sakel, D. (2025) · Springer Reference Medizin · doi:10.1007/978-3-662-65823-9_108
Thyroid Eye Disease from the Neuro-Ophthalmic Perspective
Mejía-Vergara, Á. J., & Joubert, K. P. (2025) · Advances in Ophthalmology and Optometry · doi:10.1016/j.yaoo.2025.04.004
Fattori di rischio vecchi e nuovi dell’orbitopatia basedowiana
Ciampa, D. A., Marinò, M., & Menconi, F. (2025) · L Endocrinologo · doi:10.1007/s40619-025-01651-8
Mitigating the risks: addressing smoking cessation in thyroid eye disease
Karimi, N., Kashkouli, M. B., Keyhani, A., et al. (2025) · BMJ Open Ophthalmology · doi:10.1136/bmjophth-2025-002226
“16 These findings reinforce the importance of smoking cessation in mitigating the risk of TED onset and progression.”
Call for timely prevention in thyroid eye disease: lessons from the IrTED registry
Karimi, N., Akbarian, S., Ghahvehchian, H., Kermani, B., Rad, A. M., & Kashkouli, M. B. (2025) · British Journal of Ophthalmology · doi:10.1136/bjo-2025-327392
Natural History of Thyroid Eye Disease
Pe’er, L. (2025) · Springer eBooks · doi:10.1007/978-3-031-99672-6_2
Sequence and Timing of Surgery for TED
Foo, E., & Cook, A. (2025) · Springer eBooks · doi:10.1007/978-3-031-99672-6_21
Thyroid-Associated Ophthalmopathy and Dermopathy
Wiersinga, W. M. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-517-6_9
Updates on Treatment in Thyroid Eye Disease for the Neurologist
AlRyalat, S. A., Alasheh, A., Salim, Q. F. A., & Yaaqba, N. (2026) · Neurologic Clinics · doi:10.1016/j.ncl.2025.12.002
Collin, C., Perney, P., Jeanjean, L., Raingeard, I., Julier, I., & Gilly, O. (2026) · Annales d Endocrinologie · doi:10.1016/j.ando.2026.102578
Passive Smoking and Thyroid Diseases: Association by Mendelian Randomization Study
Li, P., Cai, N., Ding, Z., Wang, J., & Wang, Q. (2026) · Neuroendocrinology · doi:10.1159/000553246
Risk factors for graves’ orbitopathy: A systematic review and meta-analysis
Cheidde, L., Amaral, D. C., Aleksander-Ivanov, Y., CAMARGO, R. P., Paião, A. T., Sales, M. C. D. C., Gil, R. A. P. G., Pereira, P. H. D. F., Miranda, B. G., Nunes, P., et al. (2026) · European Journal of Ophthalmology · doi:10.1177/11206721261470209
Sirang, Z., Khan, R., Moazzum, W., et al. (2026) · Cureus · doi:10.7759/cureus.116558
Characterisation of 11beta hydroxysteroid dehydrogenase 1 in ocular and orbital tissues
Onyimba, C. (2010) · UPT. Syiah Kuala University Library (Syiah Kuala University)
La prevenzione dell’oftalmopatia basedowiana
Bartalena, L., Tanda, M. L., & Piantanida, E. (2004) · L Endocrinologo · doi:10.1007/bf03344489
Treatment of Hyperthyroidism in Patients with Graves’ Orbitopathy
Bartalena, L. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2534-6_16
Metadata
- Authors
- Pfeilschifter, J., & Ziegler, R.
- Affiliations
- Heidelberg University (DE)
- Corresponding author
- Pfeilschifter, Johannes
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 1996-10
- Volume
- 45
- Issue
- 4
- Pages
- 477-481
- ISSN
- 0300-0664 (ISSN-L)
- 1365-2265
- OpenAlex
- W1986559988
- Cited by
- 227
- References
- 0
- Citations by year
- 2026: 5 · 2025: 11 · 2024: 9 · 2023: 11 · 2022: 9 · 2021: 9 · 2020: 12 · 2019: 9 · 2018: 7 · 2017: 4 · 2016: 15 · 2015: 7 · 2014: 17 · 2013: 7 · 2012: 6
- FWCI
- 1.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Ophthalmology › Ophthalmology and Eye Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Clinical Neurology › Myasthenia Gravis and Thymoma
- Keywords
- smoking, endocrine ophthalmopathy, Graves' hyperthyroidism, proptosis, diplopia, former smokers, risk factors
- MeSH terms
- Adult, Diplopia, Exophthalmos, Female, Graves Disease, Humans, Male, Middle Aged, Prospective Studies, Risk, Smoking, Incidence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
